Search research articles
Contact Us
Filters
Showing results (181-190 of 378) with videos related to
Page
of 38
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2004
Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells
Electron Kebebew, Miao Peng, Patrick A Treseler, et al.
Genes
|
November 10, 2019
<i>NOP53</i> as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer
Aida Orois, Sudheer K Gara, Mireia Mora, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
March 17, 2010
Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations
Wen T Shen, Lauren Ogawa, Daniel Ruan, et al.
Oncotarget
|
September 16, 2020
GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
Sudheer Kumar Gara, Monica Varun Tyagi, Dhaval Thakkur Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2017
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases
Shweta Kotian, Lisa Zhang, Myriem Boufraqech, et al.
JAMA Oncology
|
October 28, 2017
Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease
Amit Tirosh, Samira M Sadowski, W Marston Linehan, et al.
Cancer
|
December 25, 2008
Defining a molecular phenotype for benign and malignant parathyroid tumors
Gustavo G Fernandez-Ranvier, Elham Khanafshar, David Tacha, et al.
Cancer
|
November 1, 2008
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors
Karl Y Bilimoria, Wen T Shen, Dina Elaraj, et al.
Annals of Surgical Oncology
|
November 4, 2011
What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?
Richard Webb, Aarti Mathur, Richard Chang, et al.
Clinical Endocrinology
|
July 10, 2016
A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin
Naris Nilubol, Roxanne Merkel, Lily Yang, et al.
Page
of 38
Search research articles
Search
Showing results (181-190 of 378) with videos related to
Sort By:
Page
of 38
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2004
Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells
Electron Kebebew, Miao Peng, Patrick A Treseler, et al.
Genes
|
November 10, 2019
<i>NOP53</i> as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer
Aida Orois, Sudheer K Gara, Mireia Mora, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
March 17, 2010
Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations
Wen T Shen, Lauren Ogawa, Daniel Ruan, et al.
Oncotarget
|
September 16, 2020
GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
Sudheer Kumar Gara, Monica Varun Tyagi, Dhaval Thakkur Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2017
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases
Shweta Kotian, Lisa Zhang, Myriem Boufraqech, et al.
JAMA Oncology
|
October 28, 2017
Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease
Amit Tirosh, Samira M Sadowski, W Marston Linehan, et al.
Cancer
|
December 25, 2008
Defining a molecular phenotype for benign and malignant parathyroid tumors
Gustavo G Fernandez-Ranvier, Elham Khanafshar, David Tacha, et al.
Cancer
|
November 1, 2008
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors
Karl Y Bilimoria, Wen T Shen, Dina Elaraj, et al.
Annals of Surgical Oncology
|
November 4, 2011
What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?
Richard Webb, Aarti Mathur, Richard Chang, et al.
Clinical Endocrinology
|
July 10, 2016
A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin
Naris Nilubol, Roxanne Merkel, Lily Yang, et al.
Page
of 38